-
Product Insights
NewLikelihood of Approval Analysis for Retinal Vascular Occlusion
Overview How likely is it that the drugs in Retinal Vascular Occlusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Vascular Occlusion Overview Retinal vascular occlusion is a condition that...
-
Product Insights
NewLikelihood of Approval Analysis for Ischemic Stroke
Overview How likely is it that the drugs in Ischemic Stroke will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ischemic Stroke Overview Ischemic stroke occurs when there is a disruption of...
-
Product Insights
NewLikelihood of Approval Analysis for Arteritis
Overview How likely is it that the drugs in Arteritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arteritis Overview Arteritis refers to the inflammation of arteries, which are the blood...
-
Product Insights
NewLikelihood of Approval Analysis for Non-Proliferative Diabetic Retinopathy (NPDR)
Overview How likely is it that the drugs in Non-Proliferative Diabetic Retinopathy (NPDR) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-Proliferative Diabetic Retinopathy (NPDR) Overview Non-proliferative diabetic retinopathy (NPDR) is...
-
Product Insights
NewLikelihood of Approval Analysis for Proliferative Diabetic Retinopathy (PDR)
Overview How likely is it that the drugs in Proliferative Diabetic Retinopathy (PDR) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Proliferative Diabetic Retinopathy (PDR) Overview Proliferative diabetic retinopathy (PDR) is...
-
Product Insights
NewLikelihood of Approval Analysis for Thrombosis
Overview How likely is it that the drugs in Thrombosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thrombosis Overview Thrombosis is the formation of a blood clot, known as a...
-
Product Insights
NewLikelihood of Approval Analysis for Mesenchymal Tumor
Overview How likely is it that the drugs in Mesenchymal Tumor will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mesenchymal Tumor Overview Mesenchymal tumors are tumors developing from mesenchymal tissues. These...
-
Product Insights
NewLikelihood of Approval Analysis for Hemolytic Uremic Syndrome
Overview How likely is it that the drugs in Hemolytic Uremic Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hemolytic Uremic Syndrome Overview Hemolytic uremic syndrome (HUS) is a rare...
-
Product Insights
NewLikelihood of Approval Analysis for Neurofibroma
Overview How likely is it that the drugs in Neurofibroma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neurofibroma Overview Neurofibromas are benign (non-cancerous) tumors that grow on nerves in the...
-
Product Insights
NewLikelihood of Approval Analysis for Granulomatosis with Polyangiitis (Wegener’s Granulomatosis)
Overview How likely is it that the drugs in Granulomatosis with Polyangiitis (Wegener's Granulomatosis) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Overview Wegener polyangiitis is...